Get the Stockscreener App
0.3498
2.87%
0.00975
After Hours:
.34
-0.00975
-2.79%
Azitra Inc stock is traded at $0.3498, with a volume of 179.46K.
It is up +2.87% in the last 24 hours and down -33.13% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.34
Open:
$0.332
24h Volume:
179.46K
Relative Volume:
0.07
Market Cap:
$3.57M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0156
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
+12.82%
1M Performance:
-33.13%
6M Performance:
+28.11%
1Y Performance:
-29.74%
1-Day Range:
$0.332
$0.365
1-Week Range:
$0.3104
$0.3861
52-Week Range:
$0.1305
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.3498 | 3.65M | 1.27M | -11.28M | -10.46M | -22.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.15 | 107.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.00 | 78.84B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.93 | 60.05B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
915.36 | 55.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.60 | 45.09B | 447.02M | -1.18B | -906.14M | -6.1812 |
Azitra Inc Stock (AZTR) Latest News
Can Azitra Inc stock attract ESG investmentsEntry Point & Scalable Portfolio Growth Ideas - Newser
How Azitra Inc stock reacts to weak economyIPO Watch & Trade Opportunity Analysis - Newser
Will Azitra Inc stock top growth indexesPortfolio Risk Summary & Real-Time Sentiment Analysis - Newser
Is Azitra Inc. stock a buy for dividend growthJuly 2025 PostEarnings & Safe Capital Growth Tips - BỘ NỘI VỤ
Azitra Inc (AZTR) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Azitra Receives Notice of Non-Compliance from NYSE American (PR Newswire) - Aktiellt
You might want to take a look at Azitra Inc (AZTR) now - Setenews
Why analysts upgrade Azitra Inc. stockPortfolio Return Report & Reliable Intraday Trade Plans - moha.gov.vn
Azitra Inc Secures $1.5M in Private Placement - MSN
Will Azitra Inc. stock see PE expansionEntry Point & Daily Risk Controlled Trade Plans - moha.gov.vn
Azitra, Inc. Announces Reverse Stock Split (PR Newswire) - Aktiellt
Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash (PR Newswire) - Aktiellt
Is Azitra Inc stock positioned for secular growthJuly 2025 Volume & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ
[8-K] Azitra, Inc. Reports Material Event | AZTR SEC FilingForm 8-K - Stock Titan
Azitra prices 4.69M share private placement at 32c per share - MSN
Azitra announces $1.5 million private placement at premium to market By Investing.com - Investing.com Nigeria
Azitra announces $1.5 million private placement at premium to market - Investing.com India
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules - Barchart.com
Netherton Syndrome Market is Going to Booming Growth 2025-2032 | - openPR.com
Azitra, Inc. announced that it expects to receive $1.5 million in funding - MarketScreener
Can Azitra Inc stock stage a strong rebound this quarterJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Is Azitra Inc stock testing key supportDay Trade & Free Verified High Yield Trade Plans - newser.com
Why institutional investors increase stakes in Azitra Inc stockWeekly Loss Report & Verified Momentum Watchlists - newser.com
Zacks Small Cap Issues Positive Estimate for Azitra Earnings - Defense World
Is Azitra Inc stock attractive for dividend growthStock Surge & Scalable Portfolio Growth Ideas - newser.com
Is Azitra Inc. stock a smart buy before Fed meeting2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Is Azitra Inc. stock a safe buy before earnings2025 Stock Rankings & Expert Curated Trade Setups - newser.com
Why Azitra Inc stock benefits from AI revolution2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Why Azitra Inc stock could outperform next yearMarket Activity Summary & Weekly Watchlist for Consistent Profits - newser.com
Understanding Azitra Inc.’s price movementWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Why Azitra Inc stock stays on buy listsChart Signals & Daily Market Momentum Tracking - newser.com
Can Azitra Inc. stock hit analyst price targetsMarket Weekly Review & Fast Moving Market Watchlists - newser.com
Is Azitra Inc. stock positioned well for digital economyQuarterly Profit Review & Real-Time Buy Signal Notifications - newser.com
Can Azitra Inc. hit a new high this monthStop Loss & Accurate Entry/Exit Alerts - newser.com
Ranking Azitra Inc. among high performing stocks via toolsEarnings Growth Summary & Daily Entry Point Trade Alerts - newser.com
Azitra Shares Soar Pre-Market: What’s Driving The Surge? - MSN
Should I hold or sell Azitra Inc. stock in 20252025 Major Catalysts & High Yield Equity Trading Tips - newser.com
Is Azitra Inc. stock entering bullish territoryTrade Exit Report & Technical Entry and Exit Alerts - newser.com
MSN Money - MSN
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
1.02%
Cap:
|
Volume (24h):